These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 2293501

  • 1. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
    Snyder EL.
    Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M, Ikeda Y, Kurata Y, Tsubaki K, Horiuchi A, Furihata K, Kimura Y, Toyama K, Takamoto S, Tsukimoto I.
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [Abstract] [Full Text] [Related]

  • 3. Prevention of platelet alloimmunization.
    Slichter SJ.
    Prog Clin Biol Res; 1986 Apr; 211():83-116. PubMed ID: 3515365
    [Abstract] [Full Text] [Related]

  • 4. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
    Kakaiya RM, Greenstein R, Pisciotto P, Slocum SK, Rosen D, Cable RG, Morse EE, Gainey A.
    Ann Clin Lab Sci; 1985 Apr; 15(5):435-40. PubMed ID: 3933403
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM, Wollenhaupt HJ, Brüster HT.
    Beitr Infusionsther; 1991 Apr; 28():209-12. PubMed ID: 1725621
    [Abstract] [Full Text] [Related]

  • 6. Characteristics and natural history of alloimmunization following HLA-matched leukocyte transfusion in Hunter's syndrome.
    Kakaiya RK, Greenstein R, Pisciotto PT, Slocum SK, Rosen D, Cable RG, Morse EE.
    Ann Clin Lab Sci; 1984 Apr; 14(4):276-84. PubMed ID: 6431893
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients.
    Grijzenhout MA, Aarts-Riemens MI, de Gruijl FR, van Weelden H, van Prooijen HC.
    Blood; 1994 Nov 15; 84(10):3524-31. PubMed ID: 7949107
    [Abstract] [Full Text] [Related]

  • 11. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR, Hammond PB, Maniscalco CA.
    Ann Clin Lab Sci; 1986 Nov 15; 16(1):38-44. PubMed ID: 3947028
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M, Brand A, Sintnicolaas K, van Prooijen HC.
    Ned Tijdschr Geneeskd; 1988 Apr 23; 132(17):758-61. PubMed ID: 3374659
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I, O'Donnell MR, Nowicki B, Hill LR.
    Blood; 1988 May 23; 71(5):1402-7. PubMed ID: 3282572
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of HLA antibody formation in patients with hemato-oncologic diseases by using leukocyte depleted blood preparations].
    Adamzik ID, Jin J, Sachs V, Thomsen H.
    Infusionsther Transfusionsmed; 1995 Feb 23; 22(1):9-13. PubMed ID: 7727966
    [Abstract] [Full Text] [Related]

  • 15. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW.
    Blood; 1991 Jan 01; 77(1):201-5. PubMed ID: 1984797
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE, Duquesnoy RJ.
    Am J Med Technol; 1981 Feb 01; 47(2):114-20. PubMed ID: 7223758
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of patients refractory to platelet transfusion.
    Chockalingam P, Sacher RA.
    J Infus Nurs; 2007 Feb 01; 30(4):220-5. PubMed ID: 17667077
    [Abstract] [Full Text] [Related]

  • 20. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group.
    N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.